Stansky Michael P bought TLSI

May 15, 2026 · Form 4 insider transaction

Stansky Michael P bought 200,000 shares of TriSalus Life Sciences, Inc. at $2.50 per share, a transaction worth $500.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
200,000
Price
$2.50
Total value
$500.0K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateMay 15, 2026
Filing dateMay 18, 2026
Shares owned after399,698
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.; The securities reported herein are owned by Skyview Investments LLC. Mr. Stansky serves as managing member of Skyview Investments LLC (and in such capacity may be deemed to beneficially own the securities reported herein). Voting and dispositive power over the securities owned by Skyview Investments LLC is exercised in his capacity as managing member.

View the original Form 4 on SEC EDGAR
Stansky Michael P bought TLSI: May 15, 2026 | Insider Trading Screener